PROVIDER PROFILE · NPI 1285790170

Mark Levine

PRACTICEAIDS HEALTHCARE FOUNDATION TEXAS INCSee all providers at this practice →

Family PracticeHouston, TXI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

380

Beneficiaries

—

Total drug cost

$911K

Distinct drugs

Brand share

72.6%

Top prescribed drugs

Bictegrav/Emtricit/Tenofov Ala90 claims

Emtricitabine/Tenofov Alafenam32 claims

Dolutegravir Sodium27 claims

Abacavir/Dolutegravir/Lamivudi22 claims

Hydrochlorothiazide22 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$248

Payment records

By payment type

Food and Beverage$248

REFERRAL NETWORK

Where Mark Levine's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 0 inbound referrers · 3 outbound destinations.

Receives referrals from

Inbound — who sends patients here

No inbound pairs above the suppression threshold.

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
LEGACY COMMUNITY HEALTH SERVICES, INC	28	37
LEGACY COMMUNITY HEALTH SERVICES, INC	24	60
Laboratory Corporation Of America Clinical Laboratory · Houston, TX	22	44

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history